Clinical epidemiology, management and outcome of acute coronary syndromes in the Italian network on acute coronary syndromes (IN-ACS Outcome study)

Acute Cardiac Care

Volumn 14, Issue 2, 2012, Pages 71-80

  Rizzello, Vittoria ^a,b   Lucci, Donata ^b   Maggioni, Aldo P ^b   Giampaoli, Simona ^c   Greco, Cesare ^a   Pasquale, Giuseppe Di ^d   Pallotti, Maria Giovanna ^d   Mureddu, Gian Francesco ^a   Chiara, Antonio Di ^e   Boccanelli, Alessandro ^a  

^a SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^b ANMCO RESEARCH CENTER   (Italy)

^c Italian Health Institute   (Italy)

^d MAGGIORE HOSPITAL   (Italy)

^e Sant'Antonio Abate Hospital   (Italy)

Author keywords

Acute coronary syndromes; Myocardial infarction; Outcome

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DATA BASE; FEMALE; FOLLOW UP; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY BYPASS; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; OBSERVATION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK; TREATMENT OUTCOME;

EID: 84860275301     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.3109/17482941.2012.655296     Document Type: Article

References (26)

1. King III S.B. Anderson J.L. Antman E.M. et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American college of cardiology foundation/american heart association task force on practice guidelines. J. Am. Coll. Cardiol. 2009;54:2205-41.
2. The task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Th oracic Surgery (EACTS). Guidelines on myocardial revascularization. Eur Heart J. 2010;31:2501-55.
3. Fox KA, Goodman SG, Klein W, Brieger D, Steg PG, Dabbous O, et al. Management of acute coronary syndromes. Variations in practice and outcome. Findings from the global registry of acute coronary events (GRACE). Eur Heart J. 2002;23:177-89.
4. Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the euro heart survey of acute coronary syndromes (euro heart survey ACS). Eur Heart J. 2002 23 119-201
5. de Belder M, Knot J, Aaberge L, et al., European Association for Percutaneous Cardiovascular Interventions. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: Description of the current situation in 30 countries. Eur Heart J. 2010 31 943-57.
6. Goodman SG, Huang W, Yan AT, Budaj A, Kennelly BM, Gore JM, et al., Expanded global registry of acute coronary events (GRACE2) investigators. The expanded global registry of acute coronary events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am Heart J. 2009;158:193-201.
7. Casella G, Cassin M, Chiarella F, Chinaglia A, Conte MR, Fradella G, et al., BLITZ-3 investigators. Epidemiology and patterns of care of patients admitted to Italian intensive cardiac care units: The BLITZ-3 registry. J Cardiovasc Med. 2010;11:450-61.
8. Di Chiara A, Chiarella F, Savonitto S, Lucci D, Bolognese L, De Servi S, et al., BLITZ investigators. Epidemiology of acute myocardial infarction in the Italian CCU network: The BLITZ study. Eur Heart J. 2003;24:1616- 29.
9. Di Chiara A, Fresco C, Savonitto S, Greco C, Lucci D, Gonzini L, et al., BLITZ-2 investigators. Epidemiology of non-ST elevation acute coronary syndromes in the Italian cardiology network: The BLITZ-2 study. Eur Heart J. 2006;27:393-405.
10. Antman E, Bassand JP, Klein W, Ohman M, Lopez Sendon JL, Ryd é n L, et al. Myocardial infarction redefi ned-a consensus document of The Joint European Society of Cardiology/ American College of Cardiology committee for the redefi nition of myocardial infarction: The Joint European Society of Cardiology/ American College of Cardiology Committee. J Am Coll Cardiol. 2000;36:959-69.
11. Mandelzweig L, Battler A, Boyko V, Bueno H, Danchin N, Filippatos G, et al., Euro Heart Survey Investigators. The second euro heart survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean basin in 2004. Eur Heart J. 2006;27:2285-93.
12. Rogers WJ, Frederick PD, Stoehr E, Canto JG, Ornato JP, Gibson CM, et al. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the national registry of myocardial infarction from 1990 to 2006. Am Heart J. 2008;156:1026- 34.
13. Steg PG, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD, et al., GRACE investigators. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the global registry of acute coronary events (GRACE). Am J Cardiol. 2002;90:358- 63.
14. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, López-Sendón J; GRACE investigators. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: fi ndings from the global registry of acute coronary events (GRACE). Lancet 2002;359:373- 7.
15. Fox KA, Clayton TC, Damman P, Pocock SJ, de Winter RJ, Tijssen JG, et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol. 2010;55:2435- 45.
16. Damman P, Hirsch A, Windhausen F, Tijssen JG, de Winter RJ. Five-year clinical outcomes in the ICTUS (invasive versus conservative treatment in unstable coronary syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol. 2010;55:858- 64.
17. Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, et al., CRUSADE investigators. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE quality improvement initiative. JAMA 2004;292:2096- 104.
18. Yan RT, Yan AT, Tan M, Chow CM, Fitchett DH, Ervin FL, et al., Canadian Acute Coronary Syndromes (ACS) Registry Investigators. Age-related diff erences in the management and outcome of patients with acute coronary syndromes. Am Heart J. 2006;151: 352- 9.
19. Jernberg T, Johanson P, Held C, Svennblad B, Lindb ä ck J, Wallentin L., SWEDEHEART/RIKS-HIA. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA 2011;305: 1677- 84.
20. Goldberg RJ, Currie K, White K, Brieger D, Steg PG, Goodman SG, et al. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the global registry of acute coronary events (GRACE]). Am J Cardiol. 2004;93:288- 93.
21. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003;361:13- 20.
22. Stenestrand U, Lindbä c k J, Wallentin L, RIKS-HIA Registry. Longterm outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 2006;296:1749- 56.
23. Tarantini G, Razzolini R, Napodano M, Bilato C, Ramondo A, Iliceto S. Acceptable reperfusion delay to prefer primary angioplasty over fi brin-specifi c thrombolytic therapy is aff ected (mainly) by the patient?s mortality risk: 1 h does not fi t all. Eur Heart J. 2010;31:676- 83.
24. Saia F, Marrozzini C, Ortolani P, Palmerini T, Guastaroba P, Cortesi P, et al. Optimisation of therapeutic strategies for STsegment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality. Heart 2009;95:370- 76.
25. Yan AT, Tan M, Fitchett D, Chow CM, Fowlis RA, McAvinue TG, et al; Canadian acute coronary syndromes registry investigators. One-year outcome of patients aft er acute coronary syndromes (from the Canadian acute coronary syndromes registry). Am J Cardiol. 2004;94:25- 9.
26. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al., for the GRACE investigators. Prediction of risk of death and myocardial infarction in the six months aft er presentation with acute coronary syndrome: prospective multinational observational study (GRACE). Br Med J. 2006; 333:1091- 4.